Human Rights and Qualitative Health Inquiry: On Biofacism and the Importance of Parrhesia

Qualitative Inquiry and Human Rights

Volumn , Issue , 2016, Pages 218-242

  Rail, Geneviève ^a   Murray, Stuart J ^b   Holmes, Dave ^c  

^a Simone DeBeauvoir Institute   (Canada)

^b RYERSON UNIVERSITY   (Canada)

^c University of Ottawa s Institute of Mental Health Research   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84871988253     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (68)

1. Angell, M. (2004). The truth about the drug companies: How they deceive us and what to do about it. New York: Random House.
2. Barry, A., Osborne, T., & Rose, N. S. (1996). Foucault and political reason: Liberalism, neoliberalism, and rationalities of government. Chicago: University of Chicago Press.
3. Blumsohn, A. (2006). Authorship, ghost-science, access to data and control of the pharmaceutical scientific literature: Who stands behind the word? American Association for the Advancement of Science Professional Ethics Report, 19, 3, 1-4.
4. Bonell C. (1999). Evidence-based nursing: A stereotyped view of quantitative and experimental research could work against professional autonomy and authority. Journal of Advanced Nursing, 30, 1, 18-23.
5. Buetow, S. (2007). Yes, to intellectual integrity, but without the Sartrean existentialist attitude: A commentary on Murray et al. (2007) “No exit? Intellectual integrity under the regime of ‘evidence’ and ‘bestpractices.”’ Journal of Evaluation in Clinical Practice, 13, 4, 526-528.
6. Bunton, R., & Petersen, A. R. (1997). Foucault, health and medicine. New York: Routledge.
7. Clarke, A. E., Shim, J. K., Mamo, L., Fosket, J. R., & Fishman, J. R. (2003). Biomedicalization: Technoscientific transformations of health, illness, and U.S. biomedicine. American Sociological Review, 68, 2, 161-194.
8. Cohen, A. M., Stavri, P. Z., & Hersh, W. R. (2004). A categorization and analysis of the criticisms of evidence-based medicine. International Journal of Medical Informatics, 73, 1, 35-43.
9. Couto, J. (2007) Where is Sancho? A commentary on Murray et al. (2007) “No exit? Intellectual integrity under the regime of ‘evidence’ and ‘bestpractices.’” Journal of Evaluation in Clinical Practice, 13, 4, 522-523.
10. Crawford, R. (1980). Healthism and the medicalization of everyday life. International Journal of Health Services, 10, 3, 365-388.
11. Deleuze, G., & Guattari, F. (1977). Anti-Oedipus: Capitalism and schizophrenia (R. Hurley, M. Seem, and H. R. Lane, Trans.). New York: Viking Press.
12. Denzin, N. K., Lincoln, Y. S., & Giardina, M. D. (2006). Disciplining qualitative research. International Journal of Qualitative Studies in Education, 19, 6, 769-782.
13. Eribon, D. (2003). Hérésies. Paris: Fayard.
14. Foucault, M. (1977 [1975]). Discipline and punish: The birth of the prison (A. Sheridan, Trans.). New York: Pantheon Books.
15. Foucault, M. (1980). Truth and power. In C. Gordon (Ed.), Power/knowledge: Selected interviews and other writings, 1972-1977 (pp. 126-127). New York: Pantheon.
16. Foucault, M. (1997). The birth of biopolitics. In P. Rabinow (Ed.), Michel Foucault: Ethics, subjectivity, truth (pp. 73-80). New York: New Press.
17. Foucault, M. (2001). Fearless speech (J. Pearson, Ed.). Los Angeles: Semiotext(e).
18. Foucault, M. (2003). Society must be defended: Lectures at the Collège de France, 1975-1976. New York: Picador.
19. Foucault, M. (2004). Naissance de la biopolitique: Cours au Collège de France, 1978-1979. Paris: Gallimard/Seuil.
20. French, P. (2002). What is the evidence on evidence-based nursing? An epis-temological concern. Journal of Advanced Nursing, 37, 3, 250-257.
21. Freshwater, D., & Rolfe, G. (2004). Deconstructing evidence-based practice. London: Routledge.
22. Fugh-Berman, A. (2005). The corporate coauthor. Journal of General Internal Medicine, 20, 6, 546-548.
23. Giroux, H. A. (2007). The university in chains: Confronting the military-industrial-academic complex. Boulder, CO: Paradigm Publishers.
24. Goldacre, B. (2006a). Objectionable “objectives.” The Guardian, August 19, p. 8. http://www.guardian.co.uk/science/2006/aug/19/badscience.uknews (accessed February 7, 2010).
25. Goldacre, B. (2006b). Archie Cochrane: “Fascist.” http://www.badscience.net/2006/08/archie-cochrane-fascist/ (accessed February 7, 2010).
26. Goldacre, B. (2009). The danger of drugs … and data. The Guardian, May 9, p. 10. http://www.guardian.co.uk/commentisfree/2009/may/09/bad-science-medical-journals-companies (accessed February 7, 2010).
27. Goldenberg, M. J. (2006). On evidence and evidence-based medicine: Lessons from the philosophy of science. Social Science and Medicine, 62, 11, 2621-2632.
28. Gotzsche, P. C., Hróbjartsson, A., Johansen, H. K., Haahr, M. T., Altman, D. G., & Chan, A. (2007). Ghost authorship in industry-initiated randomised trials. PLoS Medicine, 4, 1, 19.
29. Grant, B. (2009). Merck published fake journal. TheScientist.com. http://www. the-scientist.com/templates/trackable/display/blog.jsp?type=blog&o_url=blog/display/55671&id=55671 (accessed September 28, 2009).
30. Holmes, D., Murray, S. J., Perron, A., & Rail, G. (2006). Deconstructing the evidence-based discourse in health sciences: Truth, power, and fascism. International Journal of Evidence-Based Healthcare, 4, 3, 180-186.
31. Holmes, D., Perron, A, & O’Byrne, P. (2006). Necrospective: Evidence, virulence, and the disappearance of nursing knowledge. Worldviews on Evidence-Based Nursing, 3, 1, 95-102.
32. Jefferson, T. (2006). How to grab a headline: Lots of smoke and little meat (Response to Holmes et al.). Letter to the Editor. International Journal of Evidence-Based Healthcare, 4, 4, 392-393.
33. Kassirer, J. P. (2005). On the take: How medicine’s complicity with big business can endanger your health. Oxford: Oxford University Press.
34. Koch, A. M. (2007). Poststructuralism and the politics of method. New York: Lexington Books.
35. Larkin, M. (1999). Whose article is it anyway? The Lancet, 354, 9189, 136.
36. Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003). Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. British Medical Journal, 326, May, 1167-1170.
37. Miettinen, O. S., & Miettinen, K. S. (2007). A commentary on Murray et al. (2007) “No exit? Intellectual integrity under the regime of ‘evidence’ and ‘best-practices.”’ Journal of Evaluation in Clinical Practice, 13, 4, 524-525.
38. Miller, P., & Rose, N. (2008). Governing the present: Administering economic, social and personal life. Cambridge: Polity Press.
39. Moffatt, B., & Elliott, C. (2007). Ghost marketing: Pharmaceutical companies and ghostwritten journal articles. Perspectives in Biology and Medicine, 50, 1, 18-31.
40. Mowatt, G., Shirran, L., Grimshaw, J. M., Rennie, D., Flanagin, A., Yank, V., MacLennan, G., Gotzsche, P., & Bero, L. A. (2002). Prevalence of honorary and ghost authorship in Cochrane Reviews. Journal of the American Medical Association, 287, 21, 2769-2771.
41. Murray, S. J. (2009). The perils of scientific obedience: Bioethics under the spectre of biofascism. In S. J. Murray and D. Holmes (Eds.), Critical interventions in the ethics ofhealthcare: Challenging the principle of autonomy in bioethics (pp. 97-113). Burlington, VT: Ashgate.
42. Murray, S. J., Holmes, D., Perron, A., & Rail, G. (2007). No exit? Intellectual integrity under the regime of “evidence” and “best-practices.” Journal of Evaluation in Clinical Practice, 13, 4, 512-516.
43. Murray, S. J., Holmes, D., Perron, A., & Rail, G. (2008). Toward an ethics of authentic practice. Journal of Evaluation in Clinical Practice, 14, 5, 682-689.
44. Murray, S. J., Holmes, D., & Rail, G. (2008). On the constitution and status of “evidence” in the health sciences. Journal of Research in Nursing, 13, 4, 272-280.
45. Ngai, S., Gold, J. L., Gill, S. S., & Rochon, P. A. (2005). Haunted manuscripts: Ghost authorship in the medical literature. Accountability in Research, 12, 3, 103-114.
46. Novas, C., & Rose, N.S. (2000). Genetic risk and the birth of the somatic individual. Economy and Society, 29, 4, 485-513.
47. Papadimos, T. J., & Murray, S. J. (2008). Foucault’s “fearless speech” and the transformation and mentoring of medical students. Philosophy, Ethics & Humanities in Medicine, 3, 12. http://www.peh-med.com/content/371/12 (accessed February 7, 2010).
48. Proctor, R. (2000). Nazi science and Nazi medical ethics: Some myths and misconceptions. Perspectives in Biology and Medicine, 43, 3, 335-346.
49. Rail, G. (2009a). Canadian youth’s discursive constructions of health in the context of obesity discourse. In J. Wright and V. Harwood (Eds.), Biopolitics and the “obesity epidemic”: Governing bodies (pp. 141-156). London: Routledge.
50. Rail, G. (2009b). Psychose en matière de santé et colonisation du corps féminin. In S. Yaya (Ed.), Pouvoir médical et santé totalitaire: Conséquences socio-anthropologiques et éthiques (pp. 251-266). Québec: Presses de l’Université Laval.
51. Rail, G., & Lafrance, M. (2009). Confessions of the flesh and biopedagogies: Discursive constructions of obesity on Nip/Tuck. Medical Humanities, 35, 2, 76-79.
52. Rose, N. (1999). Powers of freedom: Reframing political thought. Cambridge: Cambridge University Press.
53. Rose, N. (2006). The politics of life itself: Biomedicine, power, and subjectivity in the twenty-first century. Princeton, NJ: Princeton University Press.
54. Rout, M. (2009). Doctors signed Merck’s Vioxx studies. The Australian. http://www.theaustralian.news.com.au/story/02519725311725-501387100. html (accessed September 28, 2009).
55. Sackett D. (2000). Evidence-based medicine: How to practice and teach EBM. New York: Churchill Livingstone.
56. Savio, M. (1964). Untitled speech. Berkeley, CA. http://www.fsm-a.org/stacks/mario/mario_speech.html (accessed February 7, 2010).
57. Shapin, S. (1984). Pump and circumstance: Robert Boyle’s literary technology. Social Studies of Science, 14, 4, 481-520.
58. Shapin, S., & Shaffer, S. (1989). Leviathan and the air-pump. Princeton, NJ: Princeton University Press.
59. Sismondo, S. (2007). Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry? PLoS Medicine, 4, 9, 286.
60. Skrabanek, P. (1994). The death of humane medicine and the rise of coercive healthism. London: The Social Affairs Unit.
61. Smith, R. (2006). The trouble with medical journals. London: Royal Society of Medicine Press.
62. Staller, K. M. (2006). Railroads, runaways and researchers: Returning evidence rhetoric to its practice base. Qualitative Inquiry, 12, 3, 503-522.
63. Sunder Rajan, K. (2006). Biocapital: The constitution of postgenomic life. Durham, NC: Duke University Press.
64. Traynor, M. (2002). The oil crisis, risk and evidence-based practice. Nursing Inquiry, 9, 3, 162-169.
65. University of Toronto. (2010). Statement of institutional purpose. http://www.governingcouncil.utoronto.ca/policies/mission.htm#_Toc190598501 (accessed January 18, 2010).
66. Waldby, C. (2006). Umbilical cord blood: From social gift to venture capital. BioSocieties, 1, 1, 55-70.
67. Walker, K. (2003). Why evidence-based practice now?: A polemic. Nursing Inquiry, 10, 3, 145-155.
68. Winch, S., Creedy, D., & Chaboyer, W. (2002). Governing nursing conduct: The rise of evidence-based practice. Nursing Inquiry, 9, 3, 156-161.